Recent News
AimsBio Inc., a bio-analytics service provider and biotechnology company, announced today the development of high-throughput analytics specifically for the measurement of glutamine and phenylalanine.
"We are excited to release a new analytics service for glutamine and phenylalanine," said Dr. Colin Shepherd, AimsBio's president and chief executive officer. "AimsBio is rapidly advancing on several new analytics that are currently in the validation phase, but will be coming out shortly and will drive our future growth."
Glutamine is a non-essential amino acid, yet it has implications in a variety of nutritional applications and is often utilized as a nutraceutical or supplement. Phenylalanine is an essential amino acid that is important in nutritional as well as pharmaceutical and health applications. For more specific information contact info@aimsbio.com
About AimsBio, Inc.
AimsBio is a bio-analytics service provider and biotechnology company focusing on developing high-throughput bio-analytics to aid the plant breeding, seed production, ethanol production, food production, and pharmaceutical markets. The company currently offers a high-throughput bio-analytics service that measures the bio-available amino acid and phytic acid content in a variety of products. The company's R&D program is invested in developing new high-throughput bio-analytics for crops, feed, food, biofuel, and pharmaceutical applications. For more information please visit www.aimsbio.com.
